For over a decade, scientists have been growing organoids—small clusters of cells that mimic a particular organ—to serve as ...

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

Fujirebio, a leading innovator in in-vitro diagnostics, today announced a collaboration with Stanford Medicine (Location: Palo Alto, California, USA) to advance research and innovation in the field of ...